BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9440738)

  • 41. A phase I/II study of paclitaxel (TAXOL) and concurrent radiotherapy in advanced nonsmall cell lung cancer.
    Kirkbride P; Gelmon K; Eisenhauer E; Fisher B; Dulude H
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1107-11. PubMed ID: 9392551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer.
    Hihara J; Yoshida K; Hamai Y; Emi M; Yamaguchi Y; Wadasaki K
    Anticancer Res; 2007; 27(4C):2597-603. PubMed ID: 17695421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors.
    Marshall J; Chen H; Yang D; Figueira M; Bouker KB; Ling Y; Lippman M; Frankel SR; Hayes DF
    Ann Oncol; 2004 Aug; 15(8):1274-83. PubMed ID: 15277270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer.
    Suzuki M; Nishimura Y; Nakamatsu K; Kanamori S; Koike R; Kawamoto M; Mori K
    Jpn J Clin Oncol; 2003 Jun; 33(6):297-301. PubMed ID: 12913084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.
    Chen YM; Shih JF; Perng RP; Tsai CM; Whang-Peng J
    Chest; 2006 Apr; 129(4):1031-8. PubMed ID: 16608954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
    Kouroussis C; Agelaki S; Mavroudis D; Kakolyris S; Androulakis N; Kalbakis K; Souglakos J; Mallas K; Bozionelou V; Pallis A; Adamtziki H; Georgoulias V
    Anticancer Res; 2003; 23(1B):785-91. PubMed ID: 12680184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.
    Miller VA; Rigas JR; Francis PA; Grant SC; Pisters KM; Venkatraman ES; Woolley K; Heelan RT; Kris MG
    Cancer; 1995 Feb; 75(4):968-72. PubMed ID: 7842417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer.
    Rosenthal DI; Fuller CD; Machtay M; Algazy KM; Meyer DM; Kaiser LR; Yardley DA; Loiacano ME; Carbone DP
    J Thorac Oncol; 2006 Jan; 1(1):38-45. PubMed ID: 17409825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Choy H; Safran H; Akerley W; Graziano SL; Bogart JA; Cole BF
    Clin Cancer Res; 1998 Aug; 4(8):1931-6. PubMed ID: 9717821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
    Schuette W; Nagel S; Blankenburg T; Lautenschlaeger C; Hans K; Schmidt EW; Dittrich I; Schweisfurth H; von Weikersthal LF; Raghavachar A; Reissig A; Serke M
    J Clin Oncol; 2005 Nov; 23(33):8389-95. PubMed ID: 16293869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paclitaxel and simultaneous radiation in the treatment of stage III A/B non-small cell lung cancer.
    Havemann K; Wolf M; Goerg C; Faoro C; Pfab R; Diergarten K
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):19-22. PubMed ID: 8553078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paclitaxel and radiotherapy in the treatment of advanced non-small cell lung cancer.
    Marangolo M; Emiliani E; Rosti G; Giannini M; Vertogen B; Zumaglini F
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):31-4. PubMed ID: 8996595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small cell lung cancer.
    Lau D; Ryu J; Gandara D; Morgan R; Doroshow J; Wilder R; Leigh B
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):117-20. PubMed ID: 10210550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer.
    Kaira K; Tsuchiya S; Sunaga N; Yanagitani N; Watanabe S; Imai H; Hisada T; Ishizuka T; Saito R; Mori M
    Am J Clin Oncol; 2007 Feb; 30(1):51-6. PubMed ID: 17278895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer.
    Wolf M; Faoro C; Goerg C; Pfab R; Havemann K; Kettner H
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):108-12. PubMed ID: 9007135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paclitaxel as a radiation sensitizer in non-small cell lung cancer.
    Choy H; Browne MJ
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):70-4. PubMed ID: 7597436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer.
    Hosomi Y; Ohe Y; Mito K; Uramoto H; Moriyama E; Tanaka K; Kodama K; Niho S; Goto K; Ohmatsu H; Matsumoto T; Hojo F; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 1999 Nov; 29(11):546-9. PubMed ID: 10678557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Docetaxel (Taxotere) administered in weekly schedules.
    Greco FA
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):28-31. PubMed ID: 10458208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K; Sunaga N; Yanagitani N; Kawata T; Utsugi M; Shimizu K; Ebara T; Kawamura H; Nonaka T; Ishikawa H; Sakurai H; Suga T; Hara K; Hisada T; Ishizuka T; Nakano T; Mori M
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):109-14. PubMed ID: 18929446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.